Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia
Authors:
- Margarita L Martinez-FierroMargarita L Martinez-Fierro
- Idalia Garza-VelozIGIdalia Garza-Veloz
- Marcela A Espinoza-JuarezMEMarcela A Espinoza-Juarez
- Ivan Delgado-EncisoIvan Delgado-Enciso
- Edith Cardenas-VargasECEdith Cardenas-Vargas
- Rodrigo Castañeda-MirandaRCRodrigo Castañeda-Miranda
- Miguel A Cid-BaezMiguel A Cid-Baez
- 2 January 2018
- journal article
- research article
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 37 (1) , 37-50
Abstract
Background: Preeclampsia, a pregnancy disorder characterized by hypertension and proteinuria, represents the leading cause of fetal and maternal morbidity and mortality in developing countries. The identification of novel and accurate biomarkers that are predictive of preeclampsia is necessary to improve the prognosis of patients with preeclampsia. Objective: To evaluate the preeclampsia predictive value of 34 angiogenic-related proteins. Methods: We performed a nested cohort case-control study of pregnant women. The profile of the 34 proteins was evaluated at 12, 16, and 20 gestational weeks (GWs), using urine/plasma from 16 women who developed preeclampsia and 20 normotensive pregnant controls by Bio-Plex ProTM Human Cancer Biomarker Panels 1 and 2. Results: The urine concentration of soluble epidermal growth factor receptor (sEGFR), hepatocyte growth factor (HGF), angiopoietin-2 (ANG-2), endoglin (ENG), soluble fas ligand (sFASL), interleukin 6 (IL-6), placental growth factor (PLGF), and vascular endothelial growth factor A (VEGF-A) at 12 GW, prolactin (PRL), ANG-2, transforming growth factor alpha (TGF-α), and VEGF-A at 16 GW, and soluble IL-6 receptor alpha (sIL-6Rα), ANG-2 and sFASL at 20 GW, were different between groups (p < 0.05). The concentration cut-off values calculated in this study for the mentioned proteins, predicted an increased risk to developing preeclampsia in a range of 3.8–29.8 times in the study population. Conclusion: The proteins sEGFR, HGF, ANG-2, sFASL, IL-6, PLGF, VEGF-A, PRL, TGF-α FGF-b, sHER2/Neu sIL-6Rα, ENG, uPA, and insulin-like growth factor binding protein 1 (IGFBP-1), were predictive of the development of preeclampsia and their use as markers for this disease should be considered.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (-FOMIX M0024-2013-01-203220, -INFR-254106 and 225520, -SALUD-2010-138721, -SALUD-2012-01-181124, -SEP-CB-2009-01-0128567, SEP-CB-2015-258316)
This publication has 47 references indexed in Scilit:
- An Extensive Targeted Proteomic Analysis of Disease-Related Protein Biomarkers in Urine from Healthy DonorsPLOS ONE, 2013
- Mechanisms of Glomerular Albumin Filtration and Tubular ReabsorptionInternational Journal of Nephrology, 2012
- Public Health Perspectives of Preeclampsia in Developing Countries: Implication for Health System StrengtheningJournal of Pregnancy, 2011
- Urinary Proteomics for Prediction of PreeclampsiaHypertension, 2011
- Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeksUltrasound in Obstetrics & Gynecology, 2010
- Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: The need for standardization in clinical practiceThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- BASIC FIBROBLAST GROWTH FACTOR AND HYPERTENSIVE DISORDERS IN PREGNANCYHypertension in Pregnancy, 2002
- The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertension in Pregnancy, 2001
- Experience with the preclinical assessment of basic fibroblast growth factor (bFGF)Toxicology Letters, 1992
- Benign X‐Linked (Emery‐Dreifuss) Muscular Dystrophy is not BenignPacing and Clinical Electrophysiology, 1987